Viewing Study NCT04312659


Ignite Creation Date: 2025-12-24 @ 2:51 PM
Ignite Modification Date: 2026-01-01 @ 2:24 PM
Study NCT ID: NCT04312659
Status: COMPLETED
Last Update Posted: 2025-04-27
First Post: 2020-03-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Infliximab in the Treatment of Chinese Children With Crohn's Disease
Sponsor: Johnson & Johnson (China) Investment Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-07-15
Start Date Type: ACTUAL
Primary Completion Date: 2023-09-12
Primary Completion Date Type: ACTUAL
Completion Date: 2023-09-12
Completion Date Type: ACTUAL
First Submit Date: 2020-03-03
First Submit QC Date: None
Study First Post Date: 2020-03-18
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-04-25
Last Update Post Date: 2025-04-27
Last Update Post Date Type: ACTUAL